From all the data the two groups had gathered, GLP-1, specifically the 7-37 version, was starting to look like a big deal
The follow up period used to examine outcomes irrespective of ongoing use of the medication (emulating a modified intention-to-treat analysis of a clinical trial), started from the index date, and continued until study end (October 30, 2021), death, or initiation of a GLP1-RA in the DPP4i group, whichever came first (Fig
The mechanism by which PM 2.5 might cause thyroid cancer is unclear
27 In addition, GLP-1R agonists improve glycemic control, especially in individuals with insulin resistance or type 2 diabetes, further reinforcing their clinical utility
In contrast, B12 injections go directly into the bloodstream